View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Medidata Expands Collaboration with CTI Clinical Trial and Consulting,...

Medidata Expands Collaboration with CTI Clinical Trial and Consulting, Shaping a New Era of Patient-Centric Studies Medidata Patient Experience will accelerate CTI’s treatments for patients with oncology, metabolic, cardiovascular, central nervous system, and immune conditions NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and (CTI), a global leader in research services for advanced therapies, have expanded their 12-year relationship. The new agreement places the and its essential,...

 PRESS RELEASE

Temenos Earns 2025 Great Place To Work Certification™ Across 15 Locati...

Temenos Earns 2025 Great Place To Work Certification™ Across 15 Locations Temenos now certified in the US, India, Ecuador, Hong Kong and Taiwan in addition to 10 locations announced earlier this year GRAND-LANCY, Switzerland, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been Certified™ by To Work® in 15 locations in 2025. Following certification in , Temenos has recently been recognized as a Great Place to Work in an additional five locations: United States, India, Ecuador, Hong Kong and Taiwan. Great Place To Wor...

Temenos AG: 1 director

A director at Temenos AG sold/sold after exercising options 7,849 shares at 75.850CHF and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...

Russell Waller
  • Russell Waller

Orange (Buy, TP: €17, +24%) Spain buy-in, target increases to €17, +24...

Late on Friday evening Orange announced that it had agreed to buy out the 50% share in MasOrange (MO) it didn’t own for €4.25bn.

 PRESS RELEASE

Medidata Unveils Next-Generation Patient Consent Innovations, Designed...

Medidata Unveils Next-Generation Patient Consent Innovations, Designed in Partnership with Clinicians and Patient Advocates Medidata Consent, a key part of the , expedites study start-up, reduces configuration complexity, and improves patient enrollment NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced notable advances to , its industry-proven electronic informed consent technology. Delivered through the , this modern solution reimagines patient consent in clinical trial...

Farid Bitari ... (+2)
  • Farid Bitari
  • Nicolas David
Farid Bitari ... (+2)
  • Farid Bitari
  • Nicolas David
 PRESS RELEASE

UPDATE - Medidata Extends Collaboration with Sanofi for the Developmen...

UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration with Sanofi in clinical research. As part of this extension Sanofi will use the , building on the organizations’ v...

Russell Waller
  • Russell Waller

Orange (Buy, TP: €16.2, +15%) Q3 25: Solid numbers, Group EBITDAaL gui...

Orange has reported a solid set of results, with Telco revenue and EBITDA in-line with consensus expectations; Bank losses are lower than expected and Group EBITDAaL guidance has been lifted as a result (despite a small downgrade to OBS guidance).

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch